MT3 and metastatic malignant neoplasm in the lymph nodes: Interestingly, we found that DNA methylation of the MT3 promoter region (R2, from −127 to −8 sites) was significantly associated with advanced tumor stages and lymph node metastasis (Figure 6), indicating that dysfunction of MT3 through DNA methylation of the core promoter region may be associated with tumor progression.